The invention relates to a unit dose sachet comprising a perfume composition, wherein the perfume composition is a gel which comprises i) 0.2 to 2.0% by weight of a gelling agent selected from acrylates/C.sub.10-C.sub.30 alkyl acrylate cross polymers; ii) 60.0 to 75.0% by weight of a cosmetically acceptable alcohol; iii) 0.8 to 9.0% by weight of a fragrance composition having a liquid bulk specific gravity 20/20° C. of 0.97 to 1.08, a refractive index at 20° C. of 1.45 to 1.53 and a flash point of 100° C. to 1000° C.; iv) 0.5 to 1.5% by weight of a stabilizer; and v) 0.5 to 2.4% by weight of a solubilizer, vi) water up to 100% by weight, wherein the composition has a viscosity of 17,500 to 24,200 cps, and wherein the ratio of fragrance composition:gelling agent:alcohol is from 1:0.06:6 to 1:0.16:12.5.

The invention relates to a unit dose sachet comprising a perfume composition, wherein the perfume composition is a gel which comprises i) 0.2 to 2.0% by weight of a gelling agent selected from acrylates/C.sub.10-C.sub.30 alkyl acrylate cross polymers; ii) 60.0 to 75.0% by weight of a cosmetically acceptable alcohol; iii) 0.8 to 9.0% by weight of a fragrance composition having a liquid bulk specific gravity 20/20° C. of 0.97 to 1.08, a refractive index at 20° C. of 1.45 to 1.53 and a flash point of 100° C. to 1000° C.; iv) 0.5 to 1.5% by weight of a stabilizer; and v) 0.5 to 2.4% by weight of a solubilizer, vi) water up to 100% by weight, wherein the composition has a viscosity of 17,500 to 24,200 cps, and wherein the ratio of fragrance composition:gelling agent:alcohol is from 1:0.06:6 to 1:0.16:12.5.

The present invention relates to dodecandien-1-ol, dodecen-1-ol or mixtures thereof and a method of preparing same, to the use of dodecandien-1-ol, dodecen-1-ol or mixtures thereof as aroma chemical; to the use of dodecandien-1-ol, dodecen-1-ol or mixtures thereof for preparing an aroma chemical composition or for modifying the aroma character of an aroma chemical composition; to an aroma chemical composition containing dodecandien-1-ol, dodecen-1-ol or mixtures thereof; and to a method of preparing an aromatized composition or for modifying the aroma character of an aromatized composition.

The present invention relates to a fragrance or flavor composition comprising a fragrance or flavor component acting on at least one olfactory receptor polypeptide selected from the group consisting of (a) OR2C1 and OR4Q3, and (b) polypeptides which comprise an amino acid sequence sharing an identity of at least 80% with the amino acid sequence of any of the polypeptides in (a) and which are responsive to at least one offensive odor-causing substance selected from the group consisting of trans-2-nonenal, trans-2-octenal, 1-octen-3-one, 1,5-octadien-3-one, 1-octen-3-ol and 1,5-octadien-3-ol to suppress the response intensity of the olfactory receptor polypeptide(s) to at least one of the offensive odor-causing substances, and also relates to a product comprising this fragrance or flavor composition and a method for suppressing offensive odors.

Disclosed is a composition in the form of an oil-in-water emulsion and including: a) at least one oil; b) at least one cross-linked anionic polyelectrolyte; c) at least one water-in-oil emulsifying surfactant including an alkylpolyxyloside having a non-linear branched alkyl radical and having 10 to 36 carbon atoms; d) at least one oil-in-water emulsifying surfactant; e) at least one hydrophobic perfuming substance; and f) water.

The composition tonality determination method includes:

inputting at least one volatile molecule digital identifier, the volatile molecule digital identifier representative of a fragrant volatile molecule, the input defining a formula,

calculating, by a computing system, for at least one volatile molecule digital identifier of the formula, a value representative of an impact of each molecule on an activity level of an odorant receptor, represented by an odorant receptor digital identifier, each volatile molecule digital identifier being associated with at least one odorant receptor digital identifier, the association being a many-to-many association, and

determining, by a computing system, for the formula and as a function of at least one odorant receptor activity level impact calculated and a value representative of an odorant receptor activation threshold, a value representative of at least one tonality forming a composition, each odorant receptor digital identifier being associated with one tonality digital identifier, the association being a one-to-one association.

The composition tonality determination method includes:

inputting at least one volatile molecule digital identifier, the volatile molecule digital identifier representative of a fragrant volatile molecule, the input defining a formula,

calculating, by a computing system, for at least one volatile molecule digital identifier of the formula, a value representative of an impact of each molecule on an activity level of an odorant receptor, represented by an odorant receptor digital identifier, each volatile molecule digital identifier being associated with at least one odorant receptor digital identifier, the association being a many-to-many association, and

determining, by a computing system, for the formula and as a function of at least one odorant receptor activity level impact calculated and a value representative of an odorant receptor activation threshold, a value representative of at least one tonality forming a composition, each odorant receptor digital identifier being associated with one tonality digital identifier, the association being a one-to-one association.

Disclosed are antiviral essential oil compositions including one or more essential oils, such as styrax oil and resinoid, gurjun balsam oil, olibanum resinoid, nootka tree oil, vetiver oil, jatamansi oil, sandalwood oil, myrrhe oil, agarwood oil, copaiba balsam oil, ginger oil, curcuma oil, clary sage absolute, cypriol oil, rosemary oil, eucalyptus globulus, tea tree oil, patchouly oil, benzyl benzoate, vertofix(acetylated cedarwood oil), benzyl salicylate, benzyl cinnamate, cinnamyl benzoate, cinnamyl cinnamate, dihydroambrettolide, galaxolide, L-muscone, nootkatone, vetiveryl acetate, sclareol. The use of discovered fragrance molecules and essential oils alone or combination provides beneficial antiviral effects, especially for SARS-CoV-2 (COVID-19).

Compositions are provided that include a matrix and a polymeric composite particles disposed in the matrix. The polymeric composite particles include a porous polymeric core and a fragrance positioned within the porous polymeric core. Polymeric composite particles are also provided including a porous polymeric core, a fragrance positioned within the porous polymeric core, and a coating layer around the porous polymeric core. Further, a method of determining a minimum temperature of a composition is provided including providing a composition including polymeric composite particles disposed in a matrix, heating the composition, releasing at least a portion of the fragrance as a vapor from the porous polymeric core of the polymeric composite particles at or above the minimum temperature, and detecting at least a portion of the fragrance vapor in a location outside of the matrix.

A fragrance composition for use with a sanitary or incontinence article in the treatment of malodour caused by or associated with human body fluids, wherein said composition has an odour that is reminiscent of the odour of the article, as such, or the odour of the packaging material for said article, as such.